On this page
The review in brief
A working, current clinical intake with a confirmed formulation, total payment and pharmacy pathway would resolve the main commercial uncertainty. Until then, do not count OurView as a verified available Semax offer or enter the prepaid price into a lowest-cost ranking. Obtain a direct status answer and the cancellation rules before making a financial commitment.
Open the provider record
- Published price
- $135 monthly or $327 paid for three months; ordering unresolved
- Product description
- Compounded Semax nasal spray
- Access
- Ordering not confirmed
In the published record
- Nasal route and prepaid arithmetic are clear
- Third-party dispensing and illustrative imagery are acknowledged
Questions still open
- Coming-soon and stock statements conflict
- Active intake and final formulation are unconfirmed
The contradiction is on the offer itself
OurView’s Semax page identifies a nasal spray, publishes prices and shows stock language, yet the call to action says Coming Soon. Those signals do not establish an active ordering pathway. This review keeps availability unresolved instead of selecting the most favorable wording.
The three-month number is prepaid
The page displays $135 for month-to-month and $109 per month equivalent for three months paid in full, totaling $327 upfront. The lower monthly equivalent should not be presented as a single-month purchase price. It creates a larger first commitment even if the arithmetic looks attractive.
Package and dispensing need confirmation
OurView says medication is dispensed by a third-party pharmacy and images are illustrative. The page describes 30-day shipments, but does not establish the exact concentration for an approved individual prescription. A marketing image cannot supply that label or guarantee fulfillment.
Use another status review as a check
The Rx launch review separates a future service from an available product. OurView requires the same discipline even though it has a price table. A future advertised amount may help frame a question, but it is not a price that a patient can necessarily obtain today.
Do not confuse a cognitive narrative with a measured benefit
Our healthy-volunteer imaging discussion explains why changes in a brain scan do not directly establish improvement in learning or daily concentration. A clear price does not resolve that uncertainty, nor does a broad description of individualized neurological wellness.
What would change our assessment
A working, current clinical intake with a confirmed formulation, total payment and pharmacy pathway would resolve the main commercial uncertainty. Until then, do not count OurView as a verified available Semax offer or enter the prepaid price into a lowest-cost ranking. Obtain a direct status answer and the cancellation rules before making a financial commitment.
Evidence index
Original research and documented service details.
- OurView Health official Semax informationCompany website